TDOC - Teladoc Health, Inc.
Hims & Hers (NYSE:HIMS) is dominating headlines this week because the GLP-1 darling just delivered one of the ugliest quarters in the telehealth sector's short history, and bargain hunters are circling the wreckage.
Teladoc Health posts a y/y narrower Q1 loss and beats revenue estimates as international growth and cost cuts offset BetterHelp weakness and subscription declines.
Hims & Hers and Teladoc Health are taking different paths in digital health, but which stock offers stronger upside now? Let's dive in.
Teladoc Health Inc (NYSE:TDOC) shares are tumbling during Thursday's pre-market session after the company posted mixed quarterly results and issued guidance that points to continued losses. Here's what investors need to know.
Teladoc Health, Inc. (TDOC) Q1 2026 Earnings Call Transcript
While the top- and bottom-line numbers for Teladoc (TDOC) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Teladoc (TDOC) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to a loss of $0.19 per share a year ago.
Teladoc Health (NYSE:TDOC) reported mixed first-quarter financial results that have shares falling on Wednesday after market close.
NEW YORK, April 29, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended March 31, 2026 (“First Quarter 2026”). Unless otherwise noted, percentage and other changes are relative to the three months ended March 31, 2025 (“First Quarter 2025”).
HIMS broadens digital-first care with Novo Nordisk GLP-1 access, new cancer detection and Labs tools, along with expansion into Canada and Europe.
Evaluate the expected performance of Teladoc (TDOC) for the quarter ended March 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
When shopping for deals on equity markets, it's important not to catch a falling knife.
The latest trading day saw Teladoc (TDOC) settling at $5.7, representing a -3.72% change from its previous close.
Teladoc (TDOC) closed the most recent trading day at $5.69, moving 2.23% from the previous trading session.
NEW YORK, April 15, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release first quarter 2026 results on Wednesday, April 29, 2026, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day.
Shareholders are urged to contact the firm immediately at no cost or obligation, as there may be limited time to enforce your rights. We would handle the matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Teladoc Health is transitioning from a cyclical D2C model to a higher-margin, data-driven B2B platform, supporting a Buy rating at low multiples. TDOC's BetterHelp segment is pivoting to insurance reimbursement, aiming for $75–90M in 2026 insurance revenue, reducing churn and acquisition costs. Integrated Care leverages PulseAI and proprietary datasets to deliver predictive, high-ROI services to employers and health plans, supporting premium pricing and margin expansion.
Teladoc Health, Inc. (NYSE: TDOC - Get Free Report) shares crossed below its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $5.13 and traded as low as $5.06. Teladoc Health shares last traded at $5.0950, with a volume of 3,329,660 shares changing hands. Wall Street Analysts
Find out how we performed and what we learned along the way.
TDOC trades at a discount as Teladoc expands AI-driven care, cuts costs, and eyes better profitability, but BetterHelp weakness and rising competition cloud outlook.